VEON (NASDAQ:VEON – Get Free Report) had its price target boosted by research analysts at Benchmark from $56.00 to $60.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the Wireless communications provider’s stock. Benchmark’s price target suggests a potential upside of 30.70% from the company’s previous close.
VEON Stock Performance
NASDAQ:VEON opened at $45.91 on Tuesday. VEON has a twelve month low of $22.35 and a twelve month high of $48.39. The company has a quick ratio of 0.80, a current ratio of 0.81 and a debt-to-equity ratio of 2.34. The stock’s 50-day simple moving average is $44.40 and its 200 day simple moving average is $37.37. The firm has a market capitalization of $3.40 billion, a PE ratio of 8.01 and a beta of 1.47.
VEON (NASDAQ:VEON – Get Free Report) last posted its quarterly earnings results on Thursday, March 20th. The Wireless communications provider reported $0.98 earnings per share for the quarter, beating analysts’ consensus estimates of $0.92 by $0.06. The company had revenue of $998.00 million for the quarter, compared to the consensus estimate of $1.01 billion. VEON had a negative net margin of 81.71% and a positive return on equity of 36.48%.
Institutional Inflows and Outflows
VEON Company Profile
VEON Ltd., a digital operator, provides connectivity and internet services in Pakistan, Ukraine, Kazakhstan, Bangladesh, Uzbekistan, and Kyrgyzstan. It offers mobile telecommunications services, including value added and call completion, national and international roaming, wireless Internet access, mobile financial, and mobile bundle services; data connectivity, cross border transit, voice, Internet, and data services; fixed-line telecommunications using intercity fiber optic networks; and Internet-TV using Fiber to the building technology.
Further Reading
- Five stocks we like better than VEON
- The Basics of Support and Resistance
- Top 3 Insider Stock Buys in March—Are They Still Good in April?
- What is Short Interest? How to Use It
- Pharma Frenzy: Volatility Ignites Biotech Sector
- Following Congress Stock Trades
- Warren Buffett Thinks This Country Could Be the Next Big Bet
Receive News & Ratings for VEON Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VEON and related companies with MarketBeat.com's FREE daily email newsletter.